Samrat Pharmachem Ltd.

376.40 +7.05 ▲1.9%

28 February 2024, 04:01:00 PM
Volume: 3,401

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.samratpharmachem.com
Market Cap 116.30 Cr.
Enterprise Value(EV) 133.78 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 0.07 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.82 Trailing Twelve Months Ending 2023-12
Book Value / Share 205.85 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.83 Calculated using Price: 376.40
Dividend Yield 0.27 Period Ending 2023-03
No. of Shares Subscribed 0.31 Cr. 3,089,700 Shares
FaceValue 10
About Samrat Pharmachem Ltd.
Samrat Pharmachem was incorporated on June 16, 1992, at Ankleshwar in Gujarat. It was promoted by Lalit Mehta & Rajesh Mehta. The company is currently manufacturing iodine salts & bromine salts. The finished products produced by the company are used in various industries like Pharmaceuticals, Chemicals, Food, Fertilizer, Salt, etc. The products of the company are well received in Indian & foreign markets. The company is a public limited company & its shares are listed & traded on the Bombay Stock Exchange & other bourses of India. The company is presently employing 30 people for its operations at Ankleshwar & Mumbai.

Samrat Pharmachem Ltd. Delivery

Delivered Qty
Traded Qty

Samrat Pharmachem Ltd. Performance

1 Day
+1.91%
1 Week
-0.40%
1 Month
-0.67%
3 Month
+1.88%
6 Month
-8.13%
1 Year
-23.22%
2 Year
-14.84%
5 Year
+516.54%
10 Year
+1618.72%

Samrat Pharmachem Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 2.38 2.21 12.07 19.01 7.96 19.1 19.77 44.95 30.25
Return on Capital Employed (%) 6.45 5.31 16.4 23.05 11.8 22.43 23.9 52.33 34.91
Return on Assets (%) 1.1 0.97 4.86 8.37 3.79 8.6 9.22 24.2 16.57

Samrat Pharmachem Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 13 14 15 19 20 24 30 47 63 63
Non Curr. Liab. 1 2 2 1 1 0 0 0 0 1
Curr. Liab. 12 20 19 21 19 34 27 37 53 47
Minority Int.
Equity & Liab. 26 36 36 41 40 58 57 85 116 110
Non Curr. Assets 8 8 8 8 7 9 10 13 18 19
Curr. Assets 18 28 28 33 33 50 47 71 99 92
Misc. Exp. not W/O
Total Assets 26 36 36 41 40 58 57 85 116 110

Samrat Pharmachem Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 48 63 73 93 111 137 179 222 311 268
Other Income 0 0 0 0 0 1 0 1 0 1
Total Income 49 63 73 93 112 138 179 222 311 269
Total Expenditure -47 -62 -69 -87 -108 -131 -170 -198 -287 -267
PBIDT 2 1 4 6 4 7 9 25 24 2
Interest -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 0 -1 -1 -1
Taxation 0 0 -1 -2 -1 -2 -2 -6 -6 0
Exceptional Items 0 0 0
PAT 0 0 2 3 2 4 5 17 17 0
Adjusted EPS 1 1 6 10 5 14 17 56 54 0

Samrat Pharmachem Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 -1 0 -3 0 2 -1 5 17 -9
Cash Fr. Inv. 0 0 -2 1 -2 2 -2 -3 -1 -3
Cash Fr. Finan. -1 0 2 1 2 -4 2 -2 -2 10
Net Change 2 0 0 -1 -1 1 -1 0 14 -3
Cash & Cash Eqvt 2 2 4 2 1 2 0 0 15 12

Samrat Pharmachem Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 49.65 49.65 49.65 49.54 48.64 48.64 48.64 48.64 48.64
Public 50.35 50.35 50.35 50.46 51.36 51.36 51.36 51.36 51.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Samrat Pharmachem Ltd. Announcements

Wed, 21 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Extract of Standalone Un-audited Financial Results for the quarter ended December 31 2023
Wed, 14 Feb 2024
Board Meeting Outcome for Approval Of Unaudited Standalone Financial Results For The Quarter Ended December 31 2023
The Board has considered and took on record the Un-Audited Standalone Financial Results of the Company for the quarter ended December 31 2023.
Wed, 14 Feb 2024
Approval Of Unaudited Standalone Financial Results For The Quarter Ended December 31 2023
We wish to inform you that the Board has considered and took on record the Un-Audited Financial Results of the company for the quarter ended December 31 2023.

Samrat Pharmachem Ltd. Technical Scans

Tue, 27 Feb 2024
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Increase in 5 Years High Increase in 5 Years
MFI Trending Down MFI Trending Down
Mon, 26 Feb 2024
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity

Samrat Pharmachem Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 379,622.78 1,570.50 -0.7%
Cipla Ltd. 120,180.38 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. 107,577.80 6,420.70 -0.4%
Zydus Lifesciences Ltd. 95,400.24 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. 95,163.88 6,371.85 -3.7%
Divi's Laboratories Ltd. 93,921.46 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. 88,823.31 2,598.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.62 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 32.41 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.58 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 120.56 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 67.91 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.45 2,598.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.08 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-12 4.64 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.09 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-12 7.21 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.42 2,598.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,598.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,598.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,570.50 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,476.25 -0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,420.70 -0.4%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 931.25 -1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,371.85 -3.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,512.15 -0.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,598.00 -1.0%

Samrat Pharmachem Ltd. FAQ's

What is Samrat Pharmachem share price?

Can I buy Samrat Pharmachem shares now?

What is the Dividend Yield of Samrat Pharmachem?

What is the Market Cap of Samrat Pharmachem?

What are the key metrics to analyse Samrat Pharmachem?

What is the 52 Week High and Low of Samrat Pharmachem?

What is the trend of Samrat Pharmachem share price?